Comparing the current results to its competitors, Smith And Nephew Plc reported Revenue increase in the 4 quarter 2025 by 6.09 % year on year. The revenue growth was below Smith And Nephew Plc's competitors' average revenue growth of 8.53 %, achieved in the same quarter.
Smith and Nephew Plc Net Income in the 4 quarter 2025 grew year on year by 51.7%, faster than the Smith And Nephew Plc's competitors average income growth of 32.79 %
Smith And Nephew Plc's Comment on Competition and Industry Peers
Smith+Nephew operates in highly competitive markets across diverse geographic and product areas, facing competition from specialized and international corporations. Some competitors may possess greater financial, marketing, and other resources due to their size and scale, allowing them to initiate technological advances, offer products on more attractive terms, market more aggressively, or invest more in capital and research and development. Failure to adapt to competitor activity or changes in the business model could adversely affect Smith+Nephew's financial performance and reputation.
Medinotec Inc is a medical technology company that operates on a business model focused on developing and providing innovative healthcare solutions, such as medical devices and software, to improve patient care and outcomes. Their products and services cater to healthcare professionals and institutions, offering advanced technology solutions in the medical field.
Lensar Inc is a medical technology company that operates through a business model focused on the development and commercialization of advanced laser systems for ophthalmic procedures. They aim to provide innovative solutions to healthcare professionals in order to enhance precision, safety, and efficiency in eye surgeries.
Orthopediatrics Corp is a medical device company specializing in orthopedic implants and instruments for children with orthopedic conditions. Their business model revolves around designing, manufacturing, and distributing innovative pediatric orthopedic products to healthcare providers worldwide. By focusing solely on pediatric patients, they aim to address the unique needs and challenges in this niche market, providing quality solutions for improved pediatric orthopedic care.
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
Sources:
Smith and Nephew Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Smith and Nephew Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
